首页> 外文期刊>Clinical nuclear medicine >Thyroid Metastasis as First Manifestation of a Colon Adenocarcinoma With KRAS Mutation Usefulness of F-18-FDG PET/CT
【24h】

Thyroid Metastasis as First Manifestation of a Colon Adenocarcinoma With KRAS Mutation Usefulness of F-18-FDG PET/CT

机译:甲状腺转移作为结肠腺癌与KRAS突变的第一次表现为F-18-FDG PET / CT的有用性

获取原文
获取原文并翻译 | 示例
           

摘要

The synchronous diagnosis of a thyroid metastasis and of the primary colon adenocarcinoma that produces it is very rare, with only 5 cases reported to date, all of them treated with thyroid surgery showing a mean survival of 7 months. An F-18-FDG PET/CT in an asymptomatic 74-year-old woman with a thyroid cytology suggestive of malignancy but uncertain about the origin of the tumor revealed an stage IV colon adenocarcinoma with KRAS mutation and multiple metastasis (thyroid, lung, and liver). A prompt therapeutic planning with chemotherapy allowed 21 months of survival.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号